[go: up one dir, main page]

AU2002213194A1 - Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation - Google Patents

Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation

Info

Publication number
AU2002213194A1
AU2002213194A1 AU2002213194A AU1319402A AU2002213194A1 AU 2002213194 A1 AU2002213194 A1 AU 2002213194A1 AU 2002213194 A AU2002213194 A AU 2002213194A AU 1319402 A AU1319402 A AU 1319402A AU 2002213194 A1 AU2002213194 A1 AU 2002213194A1
Authority
AU
Australia
Prior art keywords
plasmin
prevention
acting
reduction
adhesion formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213194A
Inventor
Heinz Redl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of AU2002213194A1 publication Critical patent/AU2002213194A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
AU2002213194A 2000-10-13 2001-10-12 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation Abandoned AU2002213194A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24043800P 2000-10-13 2000-10-13
US60/240,438 2000-10-13
PCT/US2001/032043 WO2002030445A2 (en) 2000-10-13 2001-10-12 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation

Publications (1)

Publication Number Publication Date
AU2002213194A1 true AU2002213194A1 (en) 2002-04-22

Family

ID=22906521

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213194A Abandoned AU2002213194A1 (en) 2000-10-13 2001-10-12 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation

Country Status (3)

Country Link
US (1) US7326412B2 (en)
AU (1) AU2002213194A1 (en)
WO (1) WO2002030445A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
IL207586A0 (en) * 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
US9655621B2 (en) * 2013-03-15 2017-05-23 Covidien Lp Surgical instrument for dispensing tacks and solution
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
AU2016307447A1 (en) 2015-08-07 2018-02-22 Xcede Technologies, Inc. Adhesive compositions and related methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (en) 1979-02-15 1980-11-25 Immuno Ag METHOD FOR PRODUCING A TISSUE ADHESIVE
AT359652B (en) 1979-02-15 1980-11-25 Immuno Ag METHOD FOR PRODUCING A TISSUE ADHESIVE
AT366916B (en) 1980-04-02 1982-05-25 Immuno Ag DEVICE FOR APPLICATING A TISSUE ADHESIVE BASED ON HUMAN OR ANIMAL PROTEINS
AT379311B (en) 1984-03-29 1985-12-27 Immuno Ag DEVICE FOR APPLICATING A TISSUE ADHESIVE
AT382783B (en) 1985-06-20 1987-04-10 Immuno Ag DEVICE FOR APPLICATING A TISSUE ADHESIVE
AT388503B (en) 1987-05-21 1989-07-25 Immuno Ag SET FOR PROVIDING AND APPLICATION OF A TISSUE ADHESIVE
SE9101853D0 (en) * 1991-06-17 1991-06-17 Jonas Wadstroem IMPROVED TISSUE ASHESIVE
AT406120B (en) * 1997-08-28 2000-02-25 Immuno Ag TISSUE ADHESIVE
DE69906047T2 (en) * 1998-05-01 2003-10-16 Zymogenetics, Inc. FULLY RECOMBINANT TISSUE ADHESIVE
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
AT500670A1 (en) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa DRUGS FOR LOCAL APPLICATION
US6613325B1 (en) * 1999-06-01 2003-09-02 Bristol-Myers Squibb Company Prevention of post surgical adhesions using a fibrin monomer sealant

Also Published As

Publication number Publication date
US7326412B2 (en) 2008-02-05
WO2002030445A3 (en) 2003-08-14
US20040043016A1 (en) 2004-03-04
WO2002030445A2 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU1624801A (en) Plasminogen activator inhibitor antagonists related applications
AU2381600A (en) Thrombin or factor xa inhibitors
AU2002360983A1 (en) Adhesion inhibition of fungi
AU2002250394A1 (en) Rho-kinase inhibitors
AU2002245709A1 (en) Rho-kinase inhibitors
AU2002232575A1 (en) Nutritional composition for improving the efficacy of a lipase inhibitor
AU2108601A (en) Salicylamides as serine protease inhibitors
AU4723799A (en) Protease inhibitors
AU2001294557A1 (en) Thrombin inhibitors
AU1530001A (en) Inhibitor compositions
AU2002322802A1 (en) Thrombin inhibitors
AU4092799A (en) Protease inhibitors
AUPP982399A0 (en) Mmp inhibitor
AU2002213194A1 (en) Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
AU1393900A (en) Morpholino-ethoxybenzofuran protease inhibitors
AU9110298A (en) Protease inhibitors
AU2002349621A1 (en) Angiogenesis inhibitor
AU2002224550A1 (en) Corrosion inhibitors
AU1588901A (en) Protease inhibitors
AU1474801A (en) Protease inhibitors
AU2002351076A1 (en) Thrombin inhibitors
AU4066900A (en) Protease inhibitors
AU3888200A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors
AU1474701A (en) Protease inhibitors